Emergent Biosolutions Inc (EBS)
Cost of Revenue
$97.10M
Quarterly · Period ending: · USD
EBS Cost of Revenue
Latest reported$97.10Mperiod ending
Latest reported$97.10Mperiod ending
EBS Quarterly Cost of Revenue ($167.30M → $97.10M)
Quarterly cost of revenue
High-resolution chart · PNG
EBS cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 97,100,000 | |
| 88,500,000 | |
| 102,100,000 | |
| 102,000,000 | |
| 83,400,000 | |
| 105,700,000 | |
| 58,200,000 | |
| 129,600,000 | |
| 320,200,000 | |
| 159,600,000 | |
| 107,400,000 | |
| 178,100,000 | |
| 214,500,000 | |
| 188,600,000 | |
| 215,900,000 | |
| 188,800,000 | |
| 220,900,000 | |
| 201,800,000 | |
| 295,600,000 | |
| 266,200,000 | |
| 276,700,000 | |
| 150,700,000 | |
| 227,400,000 | |
| 204,400,000 | |
| 177,700,000 | |
| 119,000,000 | |
| 132,800,000 | |
| 161,400,000 | |
| 164,700,000 | |
| 137,900,000 | |
| 162,400,000 | |
| 106,300,000 | |
| 110,000,000 | |
| 83,400,000 | |
| 84,315,000 | |
| 66,262,000 | |
| 60,175,000 | |
| 66,397,999 | |
| 65,376,000 | |
| 66,748,000 | |
| 57,358,000 | |
| 49,294,000 | |
| 49,929,000 | |
| 69,419,000 | |
| 41,347,000 | |
| 56,150,000 | |
| 71,450,000 | |
| 76,630,000 | |
| 71,908,000 | |
| 48,841,000 | |
| 48,680,000 | |
| 49,000,000 | |
| 47,223,000 | |
| 36,422,000 | |
| 54,100,000 | |
| 37,620,000 | |
| 13,186,000 | |
| 7,511,000 | |
| 14,328,000 | |
| 10,706,000 | |
| 16,069,000 | |
| 1,068,000 | |
| 16,998,000 | |
| 11,532,000 | |
| 11,076,000 | |
| 7,508,000 | |
| 11,782,000 | |
| 8,684,000 | |
| 10,428,000 | |
| 15,368,000 | |
| 6,870,000 | |
| 10,519,000 | |
| 8,682,000 | |
| 8,010,000 | |
| 17,544,000 | |
| 11,407,000 | |
| 5,842,000 | |
| 5,516,000 | |
| 12,480,000 | |
| 3,882,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 167,300,000 | |
| 103,200,000 | |
| 134,900,000 | |
| 80,300,000 | |
| 167,300,000 |